Maine Medical Center in Portland is the first hospital in Maine to offer a new diagnostic process for prostate cancers.
The hospital is using UroNav fusion biopsy system – a technology that combines data from an MRI with that of ultrasound — to identify suspicious lesions in the prostate and precisely target and extract that tissue for testing. The technology helps determine the best course of treatment for men with, or suspected of having, prostate cancer, according to a news releases from the hospital.
“This new technology for patients on active surveillance or with elevated or rising prostate specific antigen levels comes at a time when there is increasing evidence supporting active surveillance for men with low-risk prostate cancer,” said Matthew Hayn, M.D., medical director of MMC’s genitourinary cancer program, in the release. “With this technology, men can be assured that we are recommending a treatment plan based on the most accurate biopsy available today.”
Other than skin cancer, prostate cancer is the most common form of cancer in American men and the second-leading cause of cancer death among men. In Maine, about 80 men out of every 100,000 annually will get prostate cancer and 23 will die from it, according to the Centers for Disease Control and Prevention.
Copy the Story LinkSend questions/comments to the editors.
Success. Please wait for the page to reload. If the page does not reload within 5 seconds, please refresh the page.
Enter your email and password to access comments.
Hi, to comment on stories you must . This profile is in addition to your subscription and website login.
Already have a commenting profile? .
Invalid username/password.
Please check your email to confirm and complete your registration.
Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Here’s why.
Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.